Give PrEP a chance: moving on from the “risk compensation” concept von Rojas Castro, Daniela, Delabre, Rosemary M, Molina, Jean‐Michel

Volltext

Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023 von Ambrosioni, Juan, Levi, Laura, Alagaratnam, Jasmini, Van Bremen, Kathrin, Mastrangelo, Andrea, Waalewijn, Hylke, Molina, Jean‐Michel, Guaraldi, Giovanni, Winston, Alan, Boesecke, Christoph, Cinque, Paola, Bamford, Alasdair, Calmy, Alexandra, Marzolini, Catia, Martínez, Esteban, Oprea, Cristiana, Welch, Steven, Koval, Anna, Mendao, Luis, Rockstroh, Jürgen K.

Volltext

COVID‐19–Related IgA Vasculitis von Allez, Matthieu, Denis, Blandine, Bouaziz, Jean‐David, Battistella, Maxime, Zagdanski, Anne‐Marie, Bayart, Jules, Lazaridou, Ingrid, Gatey, Caroline, Pillebout, Evangeline, Chaix Baudier, Marie‐Laure, Delaugerre, Constance, Molina, Jean‐Michel, Le Goff, Jérôme

Volltext

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4 von Onodi, Fanny, Bonnet-Madin, Lucie, Meertens, Laurent, Karpf, Lea, Poirot, Justine, Zhang, Shen-Ying, Picard, Capucine, Puel, Anne, Jouanguy, Emmanuelle, Zhang, Qian, Le Goff, Jerome, Molina, Jean-Michel, Delaugerre, Constance, Casanova, Jean-Laurent, Amara, Ali, Soumelis, Vassili

Volltext

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial von Molina, Jean-Michel, Dr, Prof, Cahn, Pedro, MD, Grinsztejn, Beatriz, MD, Lazzarin, Adriano, Prof, Mills, Anthony, MD, Saag, Michael, Prof, Supparatpinyo, Khuanchai, Prof, Walmsley, Sharon, Prof, Crauwels, Herta, PhD, Rimsky, Laurence T, PhD, Vanveggel, Simon, MSc, Boven, Katia, MD

Volltext

PrEP in Europe – expectations, opportunities and barriers von McCormack, Sheena Mary, Noseda, Veronica, Molina, Jean‐Michel

Volltext

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoprox... von DeJesus, Edwin, Rockstroh, Jürgen K, MD, Henry, Keith, MD, Molina, Jean-Michel, MD, Gathe, Joseph, MD, Ramanathan, Srinivasan, PhD, Wei, Xuelian, PhD, Yale, Kitty, MSc, Szwarcberg, Javier, MD, White, Kirsten, Prof, Cheng, Andrew K, MD, Kearney, Brian P, Prof

Volltext

Complement C5 inhibition in patients with COVID-19 - a promising target? von Peffault de Latour, Regis, Bergeron, Anne, Lengline, Etienne, Dupont, Thibault, Marchal, Armance, Galicier, Lionel, de Castro, Nathalie, Bondeelle, Louise, Darmon, Michael, Dupin, Clairelyne, Dumas, Guillaume, Leguen, Pierre, Madelaine, Isabelle, Chevret, Sylvie, Molina, Jean-Michel, Azoulay, Elie, Fremeaux-Bacchi, Veronique, Core Group

Volltext

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study von Molina, Jean-Michel, Prof, Orkin, Chloe, MD, Iser, David M, MBBS, Zamora, Francisco-Xavier, MD, Nelson, Mark, MBBS, Stephan, Christoph, Prof, Massetto, Benedetta, MD, Gaggar, Anuj, MD, Ni, Liyun, MA, Svarovskaia, Evguenia, PhD, Brainard, Diana, MD, Subramanian, G Mani, MD, McHutchison, John G, MD, Puoti, Massimo, Prof, Rockstroh, Jürgen K, Prof

Volltext

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study von Gressens, Simon B, Esnault, Violaine, De Castro, Nathalie, Sellier, Pierre, Sene, Damien, Chantelot, Louise, Hervier, Baptiste, Delaugerre, Constance, Chevret, Sylvie, Molina, Jean-Michel

Volltext

CD8 Encephalitis in HIV-Infected Patients Receiving cART: A Treatable Entity von Lescure, François-Xavier, Moulignier, Antoine, Savatovsky, Julien, Amiel, Corinne, Carcelain, Guislaine, Molina, Jean-Michel, Gallien, Sébastien, Pacanovski, Jérôme, Pialoux, Gilles, Adle-Biassette, Homa, Gray, Françoise

Volltext

Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years... von Maggiolo, Franco, Rizzardini, Giuliano, Molina, Jean‐Michel, Pulido, Federico, De Wit, Stephane, Vandekerckhove, Linos, Berenguer, Juan, D'Antoni, Michelle L., Blair, Christiana, Chuck, Susan K., Piontkowsky, David, Martin, Hal, Haubrich, Richard, McNicholl, Ian R., Gallant, Joel

Volltext

Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023 von Chaix, Marie‐Laure, Terracol, Laura, Nere, Marie‐Laure, Stefic, Karl, Lascoux‐Combe, Caroline, Manda, Victoria, Sellier, Pierre, Maylin, Sarah, Molina, Jean‐Michel, Liegeon, Geoffroy, Delaugerre, Constance, Salmona, Maud

Volltext

Tenofovir-Related Nephrotoxicity in Human Immunodeficiency Virus-Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes Insipidus von Karras, Alexandre, Lafaurie, Matthieu, Furco, André, Bourgarit, Anne, Droz, Dominique, Sereni, Daniel, Legendre, Christophe, Martinez, Frank, Molina, Jean-Michel

Volltext

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study von Molina, Jean-Michel, Prof, Clotet, Bonaventura, MD, van Lunzen, Jan, Prof, Lazzarin, Adriano, Prof, Cavassini, Matthias, MD, Henry, Keith, Prof, Kulagin, Valeriv, Prof, Givens, Naomi, MSc, de Oliveira, Carlos Fernando, MD, Brennan, Clare, DPT

Volltext

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected... von Molina, Jean-Michel, Prof, Andrade-Villanueva, Jaime, MD, Echevarria, Juan, MD, Chetchotisakd, Ploenchan, Prof, Corral, Jorge, MD, David, Neal, FCFP [SA], Moyle, Graeme, MD, Mancini, Marco, BS, Percival, Lisa, MS, Yang, Rong, PhD, Thiry, Alexandra, PhD, McGrath, Donnie, MD

Volltext

Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study von Baltes, Virginie, de Boissieu, Paul, Champenois, Karen, Luan, Louise, Seng, Rémonie, Essat, Asma, Novelli, Sophie, Spire, Bruno, Molina, Jean‐Michel, Goujard, Cécile, Meyer, Laurence

Volltext

Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit von Munier, Anne-Lise, Biard, Lucie, Legrand, Matthieu, Rousseau, Clotilde, Lafaurie, Matthieu, Donay, Jean-Luc, Flicoteaux, Rémi, Mebazaa, Alexandre, Mimoun, Maurice, Molina, Jean-Michel

Volltext

Spatio‐temporal changes in pre‐exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021: a Bayesian small area approach with MSM population estimation von Wang, Haoyi, Molina, Jean‐Michel, Dray‐Spira, Rosemary, Schmidt, Axel J., Hickson, Ford, Vijver, David, Jonas, Kai J.

Volltext

Response to “On the risk of using raw regional data on new HIV infections in France” by Tassi et al von Wang, Haoyi, Molina, Jean‐Michel, Dray‐Spira, Rosemary, Schmidt, Axel J., Hickson, Ford, Vijver, David van de, Jonas, Kai J.

Volltext